amantadine [Ligand Id: 4128] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL660 (Amantadine, Amantidine, NSC-341865, Symadine, Symmetrel, TCMDC-125869) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| GluN2D/GluN3B/GluN1/GluN2A/GluN2B/GluN2C/GluN3A/Glutamate [NMDA] receptor in Human (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL2094124] [GtoPdb: 459, 461, 455, 456, 457, 458, 460] [UniProtKB: O15399, O60391, Q05586, Q12879, Q13224, Q14957, Q8TCU5] | ||||||||
| ChEMBL | The compound was tested for its ability to block PCP N-methyl-D-aspartate glutamate receptor at the PCP (phencyclidine) binding site in postmortem human frontal cortex. | B | 4.98 | pKi | 10500 | nM | Ki | J Med Chem (1998) 41: 393-400 [PMID:9464369] |
| GtoPdb | Measured vs. exogenously expressed zeta1/epsilon3 (GRIN1/GRIN2C) subunits, at pH 6.9 | - | 4.65 | pIC50 | 22500 | nM | IC50 | J Physiol (Lond.) (2007) 581: 107-28 [PMID:17303642] |
| GluN1/GluN2A/GluN2B/GluN2C/GluN2D/GluN3B/GluN3A in Human [GtoPdb: 455, 456, 457, 458, 459, 461, 460] [UniProtKB: Q05586, Q12879, Q13224, Q14957, O15399, O60391, Q8TCU5] | ||||||||
| GtoPdb | Measured vs. exogenously expressed zeta1/epsilon3 (GRIN1/GRIN2C) subunits, at pH 6.9 | - | 4.65 | pIC50 | 22500 | nM | IC50 | J Physiol (Lond.) (2007) 581: 107-28 [PMID:17303642] |
| GluN1/GluN2A/GluN2B/GluN2C/GluN2D/GluN3B/GluN3A/Glutamate NMDA receptor in Rat (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL1907608] [GtoPdb: 455, 456, 457, 458, 459, 461, 460] [UniProtKB: P35439, Q00959, Q00960, Q00961, Q62645, Q8VHN2, Q9R1M7] | ||||||||
| ChEMBL | Antagonist activity against NMDA receptor in rat cerebellar granule neurons assessed as inhibition of NMDA -induced increase in intracellular calcium level by Fura-2 AM dye based fluorimetry | F | 4.04 | pIC50 | 92000 | nM | IC50 | Bioorg Med Chem (2009) 17: 3198-3206 [PMID:19251424] |
| ChEMBL | Antagonist activity at NMDA receptor in cerebellar granule neurons assessed as inhibition of NMDA-induced increase in intracellular calcium concentration by fluorometric assay | F | 4.04 | pIC50 | 92000 | nM | IC50 | Bioorg Med Chem (2008) 16: 9925-9936 [PMID:18954995] |
| ChEMBL | Antagonist activity at NMDA receptor in rat cerebellar granule neurons assessed as inhibition of NMDA-induced increase in intracellular calcium level by fluorometric assay | F | 4.04 | pIC50 | 92000 | nM | IC50 | Bioorg Med Chem (2010) 18: 46-57 [PMID:19954985] |
| ChEMBL | Antagonist activity at NMDA receptor in Wistar rat cerebellar granule neurons assessed as inhibition of NMDA-induced intracellular calcium by Fura-2 fluorescence assay | B | 4.04 | pIC50 | 92000 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 3333-3336 [PMID:24974339] |
| GluN1/GluN2A/Glutamate NMDA receptor; GRIN1/GRIN2A in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL1907604] [GtoPdb: 455, 456] [UniProtKB: Q05586, Q12879] | ||||||||
| ChEMBL | Displacement of [3H]-(+)-MK-801 from phencyclidine binding site of NMDA receptor in human frontal cortex after 22 hrs by scintillation counting analysis | B | 5 | pKi | 10000 | nM | Ki | Bioorg Med Chem (2015) 23: 4277-4285 [PMID:26145819] |
| GluN1/GluN2A/Glutamate NMDA receptor; Grin1/Grin2a in Rat (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2096680] [GtoPdb: 455, 456] [UniProtKB: P35439, Q00959] | ||||||||
| ChEMBL | Inhibition of eGFP-tagged rat GluN1-1a/GluN2A transfected in human tsA201 cells assessed as inhibition glutamate-induced current measured at -65 mV holding potential applied for 10 secs by whole-cell patch-clamp method | B | 4.4 | pIC50 | 40000 | nM | IC50 | Eur J Med Chem (2022) 236: 114354-114354 [PMID:35453065] |
| Influenza virus A matrix protein M2 in Influenza A virus (A/Udorn/307/1972(H3N2)) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2052] [UniProtKB: P0DOF8] | ||||||||
| ChEMBL | Binding affinity to Influenza A virus M2 transmembrane domain by analytical ultracentrifugation method | B | 4.92 | pKd | 12000 | nM | Kd | J Med Chem (2017) 60: 1716-1733 [PMID:28107633] |
| ChEMBL | Binding affinity to Influenza A virus A/Udorn/72 wild-type M2 proton channel expressed in Xenopus laevis oocytes at pH 5.5 by two-electrode voltage clamp assay | B | 5.05 | pKd | 9000 | nM | Kd | ACS Med Chem Lett (2018) 9: 198-203 [PMID:29541360] |
| ChEMBL | Binding affinity to Influenza A virus A/Udorn/72 wild-type M2 proton channel by isothermal calorimetric titration | B | 5.66 | pKd | 2170 | nM | Kd | ACS Med Chem Lett (2018) 9: 198-203 [PMID:29541360] |
| ChEMBL | Inhibition of Influenza A virus wild type M2 proton channel infected in Xenopus laevis oocytes after 2 mins by TEVC assay | B | 4.79 | pIC50 | 16100 | nM | IC50 | J Med Chem (2016) 59: 1207-1216 [PMID:26771709] |
| ChEMBL | Inhibition of wild type Influenza A virus (A/udorn/72(H3N2)) M2 channel expressed in Xenopus oocyte plasma membrane incubated for 2 mins measured over 48 to 72 hrs by two-electrode voltage clamp method | B | 4.8 | pIC50 | 16000 | nM | IC50 | J Med Chem (2014) 57: 5738-5747 [PMID:24941437] |
| ChEMBL | Inhibition of Influenza A virus A/Udorn/72 wild-type M2 proton channel expressed in Xenopus laevis oocytes assessed as blockade of inward currents at pH 5.5 after 2 mins by two-electrode voltage clamp assay | B | 4.9 | pIC50 | 12500 | nM | IC50 | ACS Med Chem Lett (2018) 9: 198-203 [PMID:29541360] |
| ChEMBL | Inhibition of Influenza A virus A/Udorn/72 wild-type M2 proton channel expressed in Xenopus laevis oocytes assessed as blockade of inward currents at pH 5.5 after 5 mins by two-electrode voltage clamp assay | B | 5.33 | pIC50 | 4700 | nM | IC50 | ACS Med Chem Lett (2018) 9: 198-203 [PMID:29541360] |
| ChEMBL | Inhibition of wild type Influenza A virus (A/chicken/Hubei/327/2004(H5N1)) M2 channel expressed in yeast after 46 to 48 hrs by yeast growth restoration assay | B | 6.18 | pEC50 | 660 | nM | EC50 | Eur J Med Chem (2018) 159: 206-216 [PMID:30292897] |
| ChEMBL | Inhibition of wild type Influenza A virus (A/chicken/Hubei/327/2004(H5N1)) M2 expressed in yeast cells after 46 to 48 hrs | B | 6.18 | pEC50 | 660 | nM | EC50 | Medchemcomm (2019) 10: 89-100 [PMID:31559005] |
| Matrix protein 2 in Influenza A virus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1932894] [UniProtKB: P06821] | ||||||||
| ChEMBL | Binding affinity to C-terminal amidated influenza A virus A/Udorn/72 (H3N2) M2 transmembrane domain (22 to 46 residues) in DPC micelles at pH 8 assessed as dissociation constant by ITC analysis | B | 5.66 | pKd | 2170 | nM | Kd | ACS Med Chem Lett (2017) 8: 145-150 [PMID:28217261] |
| ChEMBL | Binding affinity to Influenza A Weybridge(H7N7) virus Matrix protein 2 by spectrophotometry | B | 6.49 | pKd | 320 | nM | Kd | Bioorg Med Chem Lett (2010) 20: 4182-4187 [PMID:20570509] |
| ChEMBL | Inhibition of Influenza A virus (A/Udorn/72) wild type matrix protein 2 expressed in xenopus oocytes after 2 mins by two-electrode voltage clamp assay | B | 4.8 | pIC50 | 16000 | nM | IC50 | J Med Chem (2011) 54: 2646-2657 [PMID:21466220] |
| Multidrug and toxin extrusion/Multidrug and toxin extrusion protein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1743126] [GtoPdb: 1216] [UniProtKB: Q96FL8] | ||||||||
| ChEMBL | Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay | B | 4.42 | pIC50 | 37800 | nM | IC50 | J Med Chem (2013) 56: 781-795 [PMID:23241029] |
| Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
| ChEMBL | DNDI: Malaria in Vitro, 72 hour | F | 5.25 | pIC50 | 5670 | nM | IC50 | Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning |
| sigma non-opioid intracellular receptor 1/Sigma opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL287] [GtoPdb: 2552] [UniProtKB: Q99720] | ||||||||
| ChEMBL | Binding affinity towards sigma receptor in guinea pig brain membrane was determined by using [3H]DTG as the radioligand | B | 7.69 | pKi | 20.25 | nM | Ki | Bioorg Med Chem Lett (1996) 6: 595-600 |
| Organic cation transporter 1/Solute carrier family 22 member 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5685] [GtoPdb: 1019] [UniProtKB: O15245] | ||||||||
| ChEMBL | Inhibition of OCT1(unknown origin)-mediated ASP+ uptake in HEK293 cells expressing OCT1 using ASP+ as substrate incubated for 5 mins | B | 4.4 | pIC50 | 39600 | nM | IC50 | J Nat Prod (2023) 86: 191-198 [PMID:36563333] |
| Organic cation transporter 1/Solute carrier family 22 member 1 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2073670] [GtoPdb: 1019] [UniProtKB: Q63089] | ||||||||
| ChEMBL | TP_TRANSPORTER: inhibition pramipexole uptake in rOCT1-injected oocytes | F | 4.12 | pIC50 | 76300 | nM | IC50 | Drug Metab Dispos (2005) 33: 495-499 [PMID:15640376] |
| Organic cation transporter 2/Solute carrier family 22 member 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1743122] [GtoPdb: 1020] [UniProtKB: O15244] | ||||||||
| ChEMBL | Inhibition of OCT2(unknown origin)-mediated ASP+ uptake in HEK293 cells expressing OCT2 using ASP+ as substrate incubated for 5 mins | B | 4.34 | pIC50 | 45900 | nM | IC50 | J Nat Prod (2023) 86: 191-198 [PMID:36563333] |
| ChEMBL | TP_TRANSPORTER: inhibition of Dopamine uptake (Dopamine: 200 uM) in Xenopus laevis oocytes | F | 4.64 | pIC50 | 23000 | nM | IC50 | Mol Pharmacol (1998) 54: 342-352 [PMID:9687576] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
